🔹 Therapy Area

 . Anti-Diabetic / Oral Hypoglycemic Agent

🔹Generic Name

  .  Metformin Hydrochloride (SR) + Glimepiride + Voglibose Tablets

🔹Composition

• Metformin Hydrochloride (SR) – As per variant

• Glimepiride – As per variant

• Voglibose – As per variant

• Excipients q.s.

🔹Dosage Form & Strength

  . Film-coated sustained-release tablet. Strength as per the prescribed variant.                      Dosage as directed by the Physician.

🔹Clinical Information

• Indicated for Type 2 Diabetes Mellitus.

• Helps control fasting as well as post-prandial blood glucose levels.

• Improves glycemic control and reduces HbA1c when diet and exercise alone are insufficient.

🔹Pharmacological Properties

• Metformin: Reduces hepatic glucose production and improves insulin sensitivity.

• Glimepiride: Stimulates pancreatic insulin secretion, thereby lowering blood glucose levels.

• Voglibose: Delays intestinal carbohydrate absorption by inhibiting alpha-glucosidase, reducing post-meal blood sugar spikes.